Neuroinflammatory markers in patients with haemophilia and healthy controls: Where are the differences?
Udo F WehmeierValerie OrthVanessa HöppeLeonard A ValentinoThomas HilbergPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
The altered levels of sRAGE and ß-NGF in PwH, which have not been analyzed in PwH before, may help to understand the neuroinflammatory network operative in PwH. The general inflammatory processes in PwH and the involved biomarkers in PwH remain poorly understood. PwH could benefit from new therapies against neuroinflammation which may help to reduce inflammation or also chronic pain.